Ivermectin isn't a cancer miracle drug, but influencers claim otherwise

Though researchers have been studying the animal deworming drug ivermectin for decades, there is no evidence that it's a safe ...

From maternal health to influenza rates, gaps in CDC's public health data are creating dangerous blind spots

Public health relies on data—whether it is tracking the effectiveness of a given year's flu vaccine, monitoring blood lead ...
JD Supra

HHS “Operation TrialBlazer” and the Future of U.S. Clinical Trial Access, Payment, and Infrastructure Reform

On June 22, 2026, the U.S. Department of Health and Human Services (HHS) “Operation TrialBlazer”, a coordinated, department-wide initiative to ...
JD Supra

HHS “Operation TrialBlazer”: FDA Moves to Accelerate and Modernize Clinical Development

On June 22, 2026, the U.S. Department of Health and Human Services (HHS) announced the launch of Operation TrialBlazer, a coordinated effort ...
Pharmaceutical Technology on MSN

Kalohexis confidentially files IPO to back obesity and cachexia portfolio

The biotech’s potential launch on the public markets would help fuel development of its clinical-stage, melanocortin-focused ...
HealthLeaders Media

AI Scribes Are Changing the Game for Orthopedic Surgeons. Here's How.

An AI scribe that Carrell Clinic adopted about a year ago proved beneficial for orthopedic surgeons by reducing documentation ...
IEEE

The Impact of LoRA Adapters on LLMs for Clinical Text Classification Under Computational and Data Constraints

Abstract: Fine-tuning Large Language Models (LLMs) for clinical Natural Language Processing (NLP) poses significant challenges due to domain gap, limited data, and stringent hardware constraints. In ...